These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8596044)

  • 1. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.
    Young MR; Wright MA; Matthews JP; Malik I; Prechel M
    J Immunol; 1996 Mar; 156(5):1916-22. PubMed ID: 8596044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
    Young MR; Wright MA
    Cancer Res; 1992 Nov; 52(22):6335-40. PubMed ID: 1423279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas.
    Young MR; Wright MA; Pandit R
    J Immunol; 1997 Jul; 159(2):990-6. PubMed ID: 9218621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
    Young MR; McCloskey G; Wright MA; Pak AS
    Cancer Immunol Immunother; 1994 Jan; 38(1):9-15. PubMed ID: 8299123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
    Lin JY; Seguin R; Keller K; Chadee K
    Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1 alpha,25-dihydroxyvitamin D3 plus gamma-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells.
    Young MR; Halpin J; Wang J; Wright MA; Matthews J; Pak AS
    Cancer Res; 1993 Dec; 53(24):6006-10. PubMed ID: 8261414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
    J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow.
    Yamaguchi Y; Tsumura H; Miwa M; Inaba K
    Stem Cells; 1997; 15(2):144-53. PubMed ID: 9090791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha.
    Sing GK; Keller JR; Ellingsworth LR; Ruscetti FW
    J Cell Biochem; 1989 Feb; 39(2):107-15. PubMed ID: 2715197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of nitric oxide by murine bone marrow cells. Inverse correlation with cellular proliferation.
    Punjabi CJ; Laskin DL; Heck DE; Laskin JD
    J Immunol; 1992 Sep; 149(6):2179-84. PubMed ID: 1517578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
    Canque B; Camus S; Yagello M; Gluckman JC
    Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors.
    Piacibello W; Ferrero D; Sanavio F; Badoni R; Stacchini A; Severino A; Aglietta M
    Exp Hematol; 1991 Dec; 19(11):1084-9. PubMed ID: 1752317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of plasmacytoma cells on the production of granulocyte-macrophage colony-stimulating activity (GM-CSA) in the spleen of tumor-bearing mice.
    Merchav S; Apte RN; Tatarsky I; Ber R
    Exp Hematol; 1987 Oct; 15(9):995-1000. PubMed ID: 3498643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
    Yoshida M; Takeuchi M; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of various immune modulatory molecules in CD34(+) hematopoietic cells.
    Umland O; Heine H; Miehe M; Marienfeld K; Staubach KH; Ulmer AJ
    J Leukoc Biol; 2004 Apr; 75(4):671-9. PubMed ID: 14742640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.